These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15217922)

  • 1. Retinoic acid receptor beta2 hypermethylation: implications for prostate cancer detection, prevention, and therapy.
    Lotan R; Lotan Y
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3935-6. PubMed ID: 15217922
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma.
    Tokumaru Y; Harden SV; Sun DI; Yamashita K; Epstein JI; Sidransky D
    Clin Cancer Res; 2004 Aug; 10(16):5518-22. PubMed ID: 15328191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker.
    Jerónimo C; Henrique R; Hoque MO; Ribeiro FR; Oliveira J; Fonseca D; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4010-4. PubMed ID: 15217932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS; Foley R; Woodson K; Lawler M
    Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium.
    Li R; Saito T; Tanaka R; Satohisa S; Adachi K; Horie M; Akashi Y; Kudo R
    Cancer Lett; 2005 Feb; 219(1):33-40. PubMed ID: 15694662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA methylation and prostate cancer].
    Zhou SG; Sun YH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1108-12. PubMed ID: 18284062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma].
    Yao Q; He XS; Zhang JM; He J
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):28-31. PubMed ID: 16483154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.
    Bastian PJ; Ellinger J; Heukamp LC; Kahl P; Müller SC; von Rücker A
    Eur Urol; 2007 Mar; 51(3):665-74; discussion 674. PubMed ID: 16956712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein 1 suppresses the growth-inhibitory effect of retinoic acid by inhibiting retinoic acid receptor-beta2 expression via DNA methylation.
    Seo SY; Kim EO; Jang KL
    Cancer Lett; 2008 Oct; 270(1):66-76. PubMed ID: 18539384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
    Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.